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Abstract
Introduction There is growing recognition that patient-reported outcome assessment tools are important components in the holistic clinical management of patients with head and neck cancer. Single administration of such tools can provide insight into the inci-dence and prevalence of the many multifaceted and debilitating func-
tional deficits experienced by this population, while routine screening using patient-reported outcomes can assist in the early detection of “at-risk” patients and serve as a pro-cess for monitoring functional status over time. To assist the implementation of routine patient-reported outcome screening in clinical practice, an emerging body of literature has begun 
to explore the use of technology to help collect and summarise data in real-time for clinical use. The pur-pose of this review is to appraise the current evidence-base for the use of technology-assisted screening of functional patient-reported out-comes in the head and neck cancer population and to identify areas of future research need.
Materials and methodsOnline databases were searched for relevant papers published up to October 2013. In total, 44 papers 
were identified and appraised for suitability for inclusion in this review. Following critical review, seven publications were included in the 
final analysis.
ResultsFindings from the reviewed publica-tions demonstrated that technology-assisted screening of patient-reported functional status is feasible and has the potential to accurately capture the functional concerns of patients along the cancer trajectory of care. However, at present, the majority of 
studies exhibit methodological limi-tations that currently restrict the 
application of the findings to the 
broader clinical context.
ConclusionTechnology-assisted screening of functional status in the head and neck cancer population may be a solution to assist routine collection of patient-reported outcomes and optimise supportive care intervention, though further systematic research is needed. These applications have the potential to be used across cancer diagnoses, with both patients and carers, and throughout the continuum of care.
IntroductionPatients with head and neck cancer 
(HNC) undergoing definitive radio-therapy with or without chemotherapy 
[(C)RT] experience a multitude of negative health outcomes—mani-festing both as acute side-effects during treatment and perpetuating as chronic complications long-term 
post-treatment. Debilitating sequelae, including impairments to swallowing and salivary function, changes in voice quality, unintentional weight 
loss, nutritional deficiency requiring alternative feeding, poor physical functioning, as well as fatigue and distress can have a debilitating impact on quality of life (QoL), creating con-siderable survivorship burden for these patients1–3. Thus, minimising the impact of (C)RT and improving functional outcomes for this popula-tion is a priority issue in supportive cancer care. To this end, international cancer agencies4–6 and researchers7 have recommended the regular involve-ment of allied health professionals, including speech-language therapists (SLTs), to provide supportive care during and following non-surgical treatment for HNC. This supportive 
care may extend indefinitely for those with chronic swallowing and/or nutritional impairments. Unfor-tunately, international surveys of clinical practice have demonstrated 
that there are insufficient specialist services available to deliver this recommended intervention, which has the propensity to deprive HNC patients of access to best-practice care8,9. Thus, it is necessary to find an alternate service model whereby HNC patients most at-risk of swal-lowing impairment, malnutrition and distress have adequate access to supportive care intervention, within current staff and service constraints. A potential solution to assist in the 
early identification of and timely intervention for these patients is to implement routine screening during HNC treatment.
* Corresponding authorEmail: l.wall@uq.edu.au1  Centre for Functioning and Health Research, Queensland Health, Level 3, Centro Buranda, Ipswich Road, Buranda, Queensland, Australia2  Division of Speech Pathology, School of Health and Rehabilitation Sciences, The University of Queensland, St Lucia, Queensland, Australia3  Speech Pathology Department, Princess Alex-andra Hospital, Ipswich Road, Woolloongabba, Queensland, Australia
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In response to this recognised need for service delivery change, the past two decades have witnessed a shift towards the increasing use of patient-reported outcomes (PROs) in HNC management. This has facilitated the capture of subjective patient perspectives regarding not only the physical, but also the psy-chosocial effects of treatment, and has assisted in collating holistic and synergistic data to monitor overall patient function across the treat-ment continuum10. A number of PRO measures have been developed and validated as screening tools to moni-tor a range of clinical and functional outcomes, including symptom bur-den before beginning (C)RT11; side-effects, swallowing and nutritional 
status, distress/anxiety and  health-related QoL during treatment12–14; and even global status change for patients in remission15. Such tools have been shown to be feasible in 
detecting clinically significant changes in patient function16, and are rec-ognised as important secondary outcomes by treating oncologists17. However, the clinical applicability of PRO screening tools has been ques-tioned, in relation to interpreta bility and the ability to draw clinical meaningfulness in a timely manner, particularly for clinicians unfamiliar with the tool17.In light of these shortfalls, recent research has suggested that the imple-mentation of PRO-based screening tools into routine clinical practice may be assisted by the use of technology. Computer-assisted screening has the capacity to synthesise and display results in real-time, and allows clini-cians to quickly focus on the aspects of care requiring priority and/or fur-ther investigation18,19. Computerised screening of QoL has already been used in other cancer populations, including breast, lung and cancer pain clinics20,21. This research has demon-strated that technology-assisted QoL screening is feasible and results in a more productive use of waiting room 
time, greater efficiency of patient assessment processes and improved recognition of holistic aspects of patient care. Similarly, tele-monitoring of patients’ symptoms throughout treatment has been shown to be feasible and well-accepted by patients to provide support and education to manage side-effects22,23. However, the application of technology-assisted PRO screening to the HNC popu-lation is still in a nascent stage of development. Therefore, the pur-pose of this review is to critically analyse the current evidence for the use of technology-assisted screening of functional PROs in the HNC popu-lation, as a method of facilitating early detection and appropriate intervention for at-risk patients.
Materials and methodsPubMed, Medline, ScienceDirect, SpringerLink, CINAHL and Wiley data-bases were searched for electronic publications in English published in peer-reviewed journals up to October 2013. The following medical subject headings (MeSH) search terms were used: head and neck neoplasms, radiotherapy, chemoradiotherapy, deglutition and deglutition disorders. Additional search terms included head and neck cancer, patient reported outcomes, computerised screening, computerised monitoring, screening + technology/computer, swallowing, speech, nutri tion, distress, quality of life and emotional well-being. Subse-
quently, the reference lists of identified studies were manually searched for additional relevant publications.Studies were included if: (1) patients were adults diagnosed with HNC; (2) at least one functional endpoint relating to patient care was screened using a validated PRO (swallowing, 
nutrition, distress, anxiety, depres-sion, health-related or general QoL); and (3) screening was conducted using a technology-assisted medium (including computer/tablet-based inter-face or web application). Of the 46 
papers identified following initial 
searching, 37 were excluded following perusal of their abstracts: 14 papers did not use technology-assisted methods, 
21 were not specific to the HNC popu-lation, two were reviews/editorials and two did not use validated PRO measures. This left a total of seven studies eligible for inclusion in the 
final review (Table 1)24–30. Six of the seven papers were investigated by two research groups.
ResultsAll papers that met the study criteria (Table 1) reported on participant cohorts with heterogeneous disease sites. All used variations of a touch-screen-based system, with three papers (authored by the same research group) describing a customised Microsoft Access program, and the remaining reporting various com-mercially developed self-designed systems (Table 1). Reported function-ality in the systems consisted mostly of multiple-choice input and rating scales. Researchers of one study28 reported their device to be “small and portable” suggesting a tablet-based application, while others described a more static desktop computer system24. However, collectively, specific detail pertaining to the design and nature of the computerised screening medium was limited across the majority of studies.The seven papers used a range of validated tools to screen patients’ functional status electronically, includ-
ing questionnaires examining: overall 
QoL, QoL aspects specific to HNC management—particularly in regards to speech and swallowing function; 
anxiety and depression, pain, general 
distress and distresses specifically related to treatment. All but one paper used two or three questionnaires in their screening tools.While the studied cohorts, tech-nology and questionnaires trialled were relatively consistent among the included papers, study methodology and purpose varied. The research objectives of the current evidence 
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base were classifiable into two categories: (1) to evaluate the viability of administering computer-assisted data collection25,28 and/or (2) to determine the prevalence of particular 
functional deficits using an electronic screening method24,26,27,29,30. The majority of the studies used single-use, cross-sectional sampling methods at varying time-points post-treatment. The remaining three studies used a pre/post-(C)RT treatment testing design to monitor change in patient function over time. Only one study25 reported multiple post-treatment assessment points.Due to the nature of these objectives, a common limitation in the included studies was that the data obtained from the electronic screening sys-tems was not translated to inform supportive care intervention. Only one study26 actively explored the use of computerised screening to detect and facilitate referrals for multi-disciplinary care—in which 26% of 
patients identified as having speech/
swallowing difficulties post-screening were previously not known to the treating SLT, and with a proportion requiring referral for subsequent intervention. The authors concluded that the use of this electronic screening paradigm could provide a ‘safety net’ to detect patients who would otherwise fail to receive nec-essary follow-up for their functional 
difficulties. Unfortunately, the other 
six papers reported no data regarding the frequency of follow-up or referrals made to address the results obtained from the screening process. Authors of two studies27,30 recognised this issue as a methodological shortfall of their research. One paper25 reported that their electronic system had the capacity to generate a graphical summary of patients’ scores, which could be sent to the treating physician for routine clinical use. However, it did not discuss how the results of the questionnaires impacted the nature of patient care. Thus, the current scope for technology- 
assisted PRO screening to influence 
clinical decision making in the multi-disciplinary care of HNC patients is 
limited in the existing evidence base.The included papers also varied in 
the extent to which the online delivery system was validated. As previously discussed, many were simply feasibility studies or focused on the prevalence 
of functional deficits in their respective 
patient cohorts. No studies explicitly focused on establishing the sensi-
tivity and/or specificity of this novel 
service delivery model to examine true diagnostic equivalence as com-pared to the standard administration of the questionnaires (i.e. face-to-face paper-based)31. Two studies24,30 attem-pted to compare the prevalence of 
functional deficits detected by elec-tronic screening to those obtained through direct or paper-based methods, as a gauge of the reliability of the computerised tools. However, both of these studies used historical controls from other research with varying inclusionary criteria and assessment methods which restricts the conclu-sions that can be drawn. Further-more, the majority of studies stated that the computerised screening tools were quick and easy to complete, with four papers specifying the time on average for patients to complete the questionnaires (mean 8.175 min; range 7–9 min). However, as all studies lacked a direct comparison to the standard paper-based versions, they failed to quantify the time equiva-lence for using the online method.Finally, with regard to the evalua-tion of consumer perceptions, only three of the seven papers included data relating to patients’ appraisal of the computerised assessment process. Collectively, patients’ perceptions of the computerised tools were largely very positive, and the systems were deemed simple to use. Semi-structured interviews conducted by Millsopp and colleagues24 indicated that despite over 75% of the cohort having never used a computer, the majority of patients thought that they would prefer the computerised screening 
method compared to a standard paper-based version. Another study revealed that the patients were also willing to complete as many ques-tionnaires as was deemed necessary when using the system28. Research by Rogers et al.29 also showed that most patients thought completing the screening tool made a difference to the nature of the face-to-face consul-tation, including that it made it “a bit more personal”, “remind[ed] them of the points they want discussed” and “allow[ed] the consultation to get straight to the point”. This suggested that the use of technology-assisted screening of patient-reported concerns could potentially allow targeted face-to-face discussion on the most relevant 
issues and provide more efficient use of outpatient clinic time. This was a sentiment shared by a number of the papers; however, no study 
rigorously explored the impact of screening on service change—no data was presented relating to the timeliness of referrals for follow-up multidisciplinary care, numbers of unnecessary consultations that were avoided, or health economic analysis of this model of care as compared to standard face-to-face consultation. Furthermore, no included study to 
date examined clinician percep-tions of the use of computerised PRO screening. 
DiscussionThe purpose of this review was to coalesce the current evidence for the use of technology-assisted screening of PROs in the HNC population. Critical analysis of seven publications revealed that touch-screen-based systems are a feasible and insightful way of scree-ning for patient-reported functional status and have the potential to 
optimise the efficiency and holistic care approach of HNC outpatient clinics.  However, many of the included studies have similar methodological shortfalls, and these currently limit the assurance that ‘at-risk’ patients are being effectively triaged and referred 
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on for appropriate face-to-face inter-vention—which is a desired purpose of this innovative service delivery model25. While the current body of literature is limited, the heterogeneous nature of the HNC patient cohorts studied is a relative strength. This supports that technology-assisted screening could be viable for use in the routine 
clinical setting, which reflects a similar diversity in population. The variety in PRO measurements used to address multiple areas of potential functional 
deficit is also strength of the current research. This has positive indica-tions that other PRO tools, which use similar simple multiple choice ratings/scales, could be successfully translated into an online environment—thus further broadening the scope of what can be addressed by comput-erised screening. Equally, this has implications for multidisciplinary care, whereby avenues for future research could include a suite of online screening tools addressing a wide range of functional PROs, depending on the needs of the patient, to make further advances in synergistic care for this population along the treatment continuum. The consistent use of touch-screen-based computerised systems to facilitate the electronic monitoring of PROs among the included studies is aligned with broader literature, which deems touch-screen technology to be an effective tool to gather patient- related functional status informa-tion32,33. While a number of studies reported using systems built by commercial software companies, all equipment appeared to be indi-vidualised and self-designed for the purpose of the study. An overall lack 
of specificity in the papers’ method-ologies about the functions of the systems hence limits the studies’ 
repeatability to validate findings as well as the current capacity to facilitate roll-out and uptake into routine clinical practice elsewhere. This limi-tation is not surprising given that 
research into application of technology- assisted PRO screening in the HNC population is still emerging, and is likely to be addressed as the body of evidence continues to grow. The primary limitation observed across the majority of studies con-ducted to date was a lack of comparison 
and validation of findings with more conventional assessment methods. While it is acknowledged that the analysed studies have used validated measures or portions of multiple validated measures in their screening tools, researchers in the broader telemedicine paradigm have argued that diagnostic equivalence needs to 
be investigated and confirmed when the medium in which the measures are delivered has changed31. Ideally, a novel technology-assisted screening method should be compared against the current gold standard31. In this case, the gold standard is the conven-tional paper-based version or a face-to-face assessment with a relevant health professional by which the questionnaire was originally validated. Future methodologies need to use direct comparisons of data collected on both modalities (traditional gold standard and new technology- assisted methods), ideally in a blinded 
manner, to confirm the validity and sensitivity of electronic screening tools. 
Another limitation of the existing research is the lack of systematic validation of how the information obtained from online screening was used to assist patient management. As previously stated, screening systems should be designed for the purpose of triaging patients and identifying aspects of a patient’s care that requires further investigation34. Therefore, ensuring that relevant members of the multidisciplinary HNC team are alerted based on the data obtained from screening is an essential area of future development. Some of the 
analysed papers specified parameters or cut-off points for their electronic systems to deem whether a condition 
(e.g. distress) was ‘present’ or ‘absent’. Perhaps a more clinically intuitive 
method would be defining param-eters to determine the need for refer-rals for further clinical assessment 
and management. Exploration as to what is deemed a “clinically relevant change” in function, based on data obtained from screening tools, is a contentious issue and as such requires 
extensive further research16. In the meantime, however, once again, an equivalence methodology needs to be used, comparing the traditional method of practice and referral to that resulting from online screening, thus evaluating if the nature of clinical action taken following online screening is similar to traditional clinical practice. Moreover, levels of agreement between clinical judgement and detection by electronic screening could be investi-gated, as well as information regarding clinicians’ judgements of suitable screening parameters as grounds for making referrals. Such research will 
help to refine the clinical meaning-fulness and applicability of future screening systems and ensure that the data collected can be accurately used to direct multidisciplinary care. Finally, for screening to be effective, it must use methods that are accept-able to patients and clinicians35,36. Unfortunately, the current investi-gations are limited in their analysis of consumer perceptions and future research, therefore, requires a more comprehensive focus on the views of all stakeholders (i.e. patients, carers and staff), to negate any potential barriers to clinical implementation. Consideration of the economic feasi-bility of this new service delivery model as compared to current stan-dard practice is also an essential area of future analysis, to facilitate the uptake of electronic screening into routine clinical care.
ConclusionThis review has critically appraised the current evidence for the use of technology-assisted screening of 
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functional PROs in HNC patients, and their potential for facilitating accurate and prompt detection of, and intervention with, at-risk patients. Collective analysis has demonstrated that this novel service-delivery model is a viable triage tool and has the potential to inform and optimise supportive care intervention. This has positive implications for HNC patients who face often substantial 
functional difficulties both during treatment and long into the survivor-ship phase. It also has great potential for supporting carers, who may also be 
experiencing considerable distress or QoL disturbance as a result of their family member undergoing HNC management. The recognised limi-
tations of the existing literature can be used to develop future feasi-bility studies with discriminating methodological rigour and focus on the clinical applicability of screening systems. Addressing such limitations is an avenue for further research and is necessary if technology-assisted 
screening is to be effectively and effi-ciently implemented in routine clinical practice.
Abbreviations list
CINAHL, Cumulative Index to Nursing and Allied Health Literature; (C)RT, chemoradiotherapy; HNC, head and neck cancer; MeSH, medical subject heading; PRO, patient-reported out-come; QoL, quality of life.
References
1. van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Hilgers FJ. Functional outcomes and rehabili-tation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol. 2009 Jun;266(6):889–900.
2. Jacobi I, van der Molen L, Huiskens H, Van Rossum MA, Hilgers FJ. Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a system-atic review. Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1495–505.
3. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment- 
related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol. 2008 Aug;26(22):3770–6.
4. Health Workforce Australia [http://www.hwa.gov.au/sites/uploads/HWA-National-Cancer-Workforce-Strategy-Framework.pdf]. The National Cancer Workforce Strategy Framework; 2012 [accessed 28 October 2013].
5. Network NCC [www.nccn.org]. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers version 1.2012. 2012 [accessed 19 March 2013].
6. Allied Health Professions’ Office of Queensland. Discussion paper: Allied 
health staffing in Queensland Health Cancer Care Services. Brisbane, Australia: Queensland Health; Draft, December 2012.
7. Starmer HM, Gourin CG. Is speech lan-guage pathologist evaluation necessary in the nonoperative treatment of head and neck cancer? Laryngoscope. 2013 Jun;123(7):1571–2.
8. Roe JW, Carding PN, Rhys-Evans PH, Newbold KL, Harrington KJ, Nutting CM. Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom–a web-based survey. Oral Oncol. 2012 Apr;48(4):343–8.
9. Krisciunas GP, Sokoloff W, Stepas K, Langmore SE. Survey of usual practice: dysphagia therapy in head and neck cancer patients. Dysphagia. 2012 Dec; 27(4):538–49.
10. Bateman E, Keefe D. Patient-reported outcomes in supportive care. Semin Oncol. 2011 Jun;38(3):358–61.
11. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, et al. High symptom burden prior to radiation therapy for head and neck cancer: a patient- reported outcomes study. Head Neck. 2013 Oct;35(10):1490–8.
12. Epstein JB, Beaumont JL, Gwede CK, Murphy B, Garden AS, Meredith R, et al. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer. 2007 May;109(9):1914–22.
13. Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress ther-mometer and other ultra-short methods of 
detecting cancer-related mood disorders. J Clin Oncol. 2007 Oct;25(29):4670–81.
14. Gabrielson DK, Scaffidi D, Leung E, Stoyanoff L, Robinson J, Nisenbaum R, et al. Use of an abridged scored Patient-Generated Subjective Global Assessment (abPG-SGA) as a nutritional screening tool for cancer patients in an outpa-tient setting. Nutr Cancer. 2013 Mar; 65(2):234–9.
15. Ghazali N, Lowe D, Rogers SN. Enhanced patient reported outcome measurement suitable for head and neck cancer follow-up clinics. Head Neck Oncol. 2012 Jun;4(1):1–9.
16. Ringash J, O’Sullivan B, Bezjak A, Redelmeier DA. Interpreting clinically 
significant changes in patient‐reported outcomes. Cancer. 2007 Jul;110(1): 196–202.
17. Meldahl ML, Acaster S, Hayes RP. 
Exploration of oncologists’ attitudes toward and perceived value of patient-reported outcomes. Qual Life Res. 2013 May;22(4):725–31.
18. Hilarius DL, Kloeg PH, Gundy CM, Aaronson NK. Use of health‐related quality‐ of‐life assessments in daily clinical oncology nursing practice. Cancer. 2008 Aug;113(3):628–37.
19. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, et al. Mea-suring quality of life in routine oncol-ogy practice improves communication 
and patient well-being: a randomized controlled trial. J Clin Oncol. 2004 Feb; 22(4):714–24.
20. 20. Carlson LE, Speca M, Hagen N, 
Taenzer P. Computerized quality-of-life screening in a cancer pain clinic. J Palliat Care. 2001Jan;17(1):46–52.
21. Carlson LE, Groff SL, Maciejewski O, 
Bultz BD. Screening for distress in lung and 
breast cancer outpatients: a randomized controlled trial. J Clin Oncol. 2010 Nov; 28(33):4884–91.
22. Head BA, Keeney C, Studts JL, Khayat M, Bumpous J, Pfeifer M. Feasibility and acceptance of a telehealth interven-tion to promote symptom management during treatment for head and neck cancer. J Support Oncol. 2011 Jan;9(1): e1–e11.
23. Head BA, Studts JL, Bumpous JM, Gregg JL, Wilson L, Keeney C, et al. Devel-opment of a telehealth intervention for head and neck cancer patients. Telemed E Health. 2009 Jan;15(1):44–52.
Page 7 of 7
Critical Review
Co
m
pe
ti
ng
 in
te
re
st
s:
 n
on
e 
de
cl
ar
ed
. C
on
fli
ct
 o
f i
nt
er
es
ts
: n
on
e 
de
cl
ar
ed
.
A
ll 
au
th
or
s 
co
nt
ri
bu
te
d 
to
 t
he
 c
on
ce
pti
on
, d
es
ig
n,
 a
nd
 p
re
pa
ra
ti
on
 o
f t
he
 m
an
us
cr
ip
t,
 a
s 
w
el
l a
s 
re
ad
 a
nd
 a
pp
ro
ve
d 
th
e 
fin
al
 m
an
us
cr
ip
t.
A
ll 
au
th
or
s 
ab
id
e 
by
 t
he
 A
ss
oc
ia
ti
on
 fo
r 
M
ed
ic
al
 E
th
ic
s 
(A
M
E)
 e
th
ic
al
 r
ul
es
 o
f d
is
cl
os
ur
e.
Licensee OA Publishing London 2013. Creative Commons Attribution License (CC-BY)For citation purposes: Wall LR, Ward EC, Cartmill B, Hill AJ. Technology-assisted screening of patient-reported functional outcomes in the head and neck cancer population: What’s the evidence? OA Cancer 2013 Oct 01;1(2):13.
24 Cnossen IC, de Bree R, Rinkel RN, Eerenstein SE, Rietveld DH, Doornaert P, 
et al. Computerized monitoring of patient-reported speech and swallowing problems in head and neck cancer patients in clinical practice. Support Care Cancer. 2012 Nov;20(11):2925–31.
25. De Bree R, Verdonck‐de Leeuw I, 
Keizer A, Houffelaar A, Leemans C. Touch screen computer‐assisted health‐related quality of life and distress data collection in head and neck cancer patients. Clin Otolaryngol. 2008 Apr; 33(2):138–42.
26. Ghazali N, Kanatas A, Scott B, Lowe D, Zuydam A, Rogers SN. Use of the Patient Concerns Inventory to identify speech and swallowing concerns following treatment for oral and oropharyngeal cancer. J Laryngol Otol. 2012 Aug;126(8): 800–8.
27. Maher NG, Britton B, Hoffman GR. Early screening in patients with head and 
neck cancer identified high levels of pain 
and distress. J Oral Maxillofac Surg. 2013 Aug;71(8):1458–64.
28. Millsopp L, Frackleton S, Lowe D, Rogers S. A feasibility study of computer- assisted health-related quality of life data collection in patients with oral and 
oropharyngeal cancer. Int J Oral Maxillofac Surg. 2006 Aug;35(8):761–4.
29. Rogers SN, El-Sheikha J, Lowe D. The development of a Patients Concerns Inventory (PCI) to help reveal patients concerns in the head and neck clinic. Oral Oncol. 2009 Jul;45(7):555–61.
30. Verdonck-de Leeuw IM, de Bree R, 
Keizer AL, Houffelaar T, Cuijpers P, van 
der Linden MH, et al. Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psy-chosocial care. Oral Oncol. 2009 Oct; 45(10):e129–e33.
31. Nelson EL, Palsbo S. Challenges in telemedicine equivalence studies. Eval Program Plann. 2006 Nov;29(4): 419–25.
32. Carter G, Britton B, Clover K, Rogers K, Adams C, McElduff P. Effectiveness of QUICATOUCH: a computerised touch 
screen evaluation for pain and distress in ambulatory oncology patients in Newcastle, Australia. Psychooncology. 2012 Nov;21(11):1149–57.
33. Velikova G, Brown J, Smith A, Selby P. Computer-based quality of life question-naires may contribute to doctor–patient interactions in oncology. Br J Cancer. 2002 Jan;86(1):51–9.
34. Streiner DL. Diagnosing tests: using and misusing diagnostic and screen-ing tests. J Pers Assess. 2003 Dec; 81(3):209–19.
35. Clover K, Carter GL, Adams C, Hickie I, Davenport T. Concurrent validity of the PSYCH-6, a very short scale for detecting 
anxiety and depression, among oncology outpatients. Aust N Z J Psychiatry. 2009 Jul;43(7):682–8.
36. Clover K, Carter GL, Mackinnon A, Adams C. Is my patient suffering clinically 
significant emotional distress? Demonstra-tion of a probabilities approach to evaluat-ing algorithms for screening for distress. Support Care Cancer. 2009 Dec;17(12): 1455–62.
